“OCLI Vision is known for their tremendous work in the ophthalmic field. Aligning with such a great group will allow us to provide even higher levels of care to the patients we dutifully serve,” noted Dr. Armesto.
MECHANICSBURG, Pa. (PRWEB)
September 22, 2022
OCLI Vision and Spectrum Vision Partners are delighted to announce the acquisition of Armesto Eye Associates. The multi-specialty ophthalmology practice consists of David M. Armesto, MD, FACS (the first physician to perform LASIK in Central Pennsylvania); Mary Ann Bonomo Hosey, OD; and Troy Hosey, OD. Armesto Eye Associates brings the number of OCLI Vision clinic locations to 13 in the Pennsylvania region.
OCLI Vision is a leading ophthalmology practice whose growth is supported by the management and administrative services of Spectrum Vision Partners (SVP), an organization serving many of the top ophthalmologists, optometrists and ambulatory eye surgery centers in New York, New Jersey, Connecticut, Pennsylvania, and West Virginia.
“I’m very excited to have the first-rate doctors and surgeons at Armesto Eye Associates join the OCLI Vision Team,” noted Tom Burke, SVP’s CEO. “The practice is a tremendous addition to our growing network.”
The experienced team at Armesto Eye Associates provides first-class care across various ophthalmic disciplines. The clinic is located in the Fredricksen Outpatient Center (Pinnacle Building) at the Cumberland Technology Park, a 260-acre business center at Wertzville Road and Route I-81 in Hampden Township.
“OCLI Vision is known for their tremendous work in the ophthalmic field. Aligning with such a great group will allow us to provide even higher levels of care to the patients we dutifully serve,” noted Dr. Armesto.
The office is located at 2015 Technology Pkwy, Suite 103, Mechanicsburg, PA 17050.
For questions or further information regarding the OCLI Vision team or Spectrum Vision Partners, please contact:
Tom Burke
Chief Executive Officer
tburke@spectrumvisionpartners.com
Greg Wappett
Chief Development Officer
gwappett@spectrumvisionpartners.com
About OCLI Vision
Founded in 1997, OCLI Vision (http://www.ocli.net) is one of the leading ophthalmology practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.
About Spectrum Vision Partners
Spectrum Vision Partners (SVP) (http://www.spectrumvisionpartners.com) is a leading management services organization, serving the ophthalmology sector. With nearly 1,300 employees providing world-class practice management and administrative solutions to a network of nationally renowned, multi-specialty ophthalmologists in New York, New Jersey, Connecticut, Pennsylvania and West Virginia, SVP supports over 40 clinic locations, five state-licensed ambulatory surgery centers, and over 125 surgeons, doctors and other medical professionals. SVP provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management and information technology. The company’s corporate service center is located at 825 East Gate Boulevard, Suite 111, Garden City, NY 11530.
About Blue Sea Capital
Blue Sea Capital (http://www.blueseacapital.com) is a private equity firm based in West Palm Beach, Florida, that invests in growth-oriented lower middle market companies valued up to $250 million. The firm has more than $750 million in assets under management and invests across three industry verticals: aerospace & defense, healthcare, and industrial growth. Blue Sea Capital’s strategy is to partner with talented managers and differentiated companies, typically as the first or second institutional investor, and deliver strategic and operational value-add that drives growth acceleration, industry outperformance and business transformation.
Share article on social media or email: